Frontier
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 28, 2012; 18(44): 6357-6375
Published online Nov 28, 2012. doi: 10.3748/wjg.v18.i44.6357
Table 4 Questions for future study
What is the ideal timing for influence of proliferative and differentiation phases in small bowel adaptation with targeted therapy?
What are useful combination regimens of multimodality therapy?
What dietary supplementation is essential for optimization of adaptation?
What is an appropriate algorithm for advanced medical compared to surgical treatment of small bowel syndrome ?
What is the precise role for glutamine supplementation in facilitating adaptation?
What is the ideal dose of Teduglutide?
Can other agents such as polyamines or retinoic acid be useful?
How can surgical procedures best be combined with multimodal therapy?
How can the role of physical force in adaptation be replaced pharmacologically?
Why is neoplasm more common in the large intestine than in the small intestine?
Why do APC (Min) mice have more common neoplasms in the small bowel?